Profile data is unavailable for this security.
About the company
AddLife AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The Company operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The Company operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.
- Revenue in SEK (TTM)8.84bn
- Net income in SEK717.60m
- Incorporated2014
- Employees2.12k
- LocationAddLife ABBrunkebergstorg 5, Box 3145STOCKHOLM 103 62SwedenSWE
- Phone+46 842003830
- Websitehttps://www.add.life/
More ▼
Mergers & acquisitions
| Acquired company | ALIF B:STO since announced | Transaction value |
|---|---|---|
| O'Flynn Medical Ltd | -38.11% | -- |
| BioCat GmbH | -38.11% | -- |
| MBA Incorporado SL | -52.28% | 125.24m |
| Telia Sverige AB-Telia Health Monitoring | -49.19% | -- |
| Camanio AB | -53.05% | 7.21m |
Data delayed at least 15 minutes, as of Jun 23 2022 17:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bonesupport Holding AB | 234.40m | -81.69m | 4.41bn | 86.00 | -- | 17.72 | -- | 18.80 | -1.27 | -1.27 | 3.65 | 3.86 | 0.6041 | 0.4913 | 7.01 | 2,547,804.00 | -21.05 | -35.30 | -24.97 | -44.57 | 89.60 | 87.87 | -34.85 | -84.28 | 3.84 | -73.97 | 0.0796 | -- | 17.71 | 15.27 | 15.66 | -- | 19.98 | -- |
| Calliditas Therapeutics AB | 279.08m | -581.89m | 5.08bn | 71.00 | -- | 5.92 | -- | 18.19 | -11.38 | -11.38 | 5.47 | 16.38 | 0.2077 | 1.08 | 88.21 | 4,228,500.00 | -43.88 | -31.46 | -49.82 | -34.68 | 17.60 | -- | -211.31 | -288.51 | 5.36 | -88.31 | 0.1976 | -- | 26,141.08 | -- | -15.41 | -- | 145.12 | -- |
| Zealand Pharma A/S | 373.48m | -1.38bn | 6.58bn | 345.00 | -- | 5.99 | -- | 17.61 | -22.16 | -23.12 | 6.02 | 16.42 | 0.1297 | 1.99 | 3.89 | 731,901.40 | -47.76 | -31.81 | -57.58 | -37.07 | 62.29 | -- | -368.33 | -247.19 | 4.78 | -- | 0.5268 | -- | -17.19 | 4.85 | -20.24 | -- | 53.47 | -- |
| Surgical Science Sweden AB | 488.71m | 101.20m | 7.69bn | 224.00 | 59.52 | 2.09 | 54.27 | 15.74 | 2.54 | 2.54 | 11.73 | 72.32 | 0.1935 | 2.22 | 6.80 | 2,338,335.00 | 4.01 | 3.41 | 4.27 | 3.67 | 69.07 | 78.80 | 20.71 | 15.42 | 2.18 | -- | 0.0432 | 0.00 | 249.98 | 47.90 | 452.66 | 92.43 | 4.25 | -- |
| Nykode Therapeutics ASA | 346.26m | -99.18m | 9.12bn | 128.00 | -- | 4.78 | -- | 26.33 | -0.3843 | -0.3843 | 1.18 | 6.40 | 0.1433 | -- | 3.82 | 3,301,744.00 | -4.10 | 25.30 | -4.53 | 27.55 | -- | -- | -28.64 | 46.19 | -- | -- | 0.0357 | -- | -84.20 | 311.05 | -106.29 | -- | 157.24 | -- |
| BioGaia AB | 866.99m | 222.13m | 9.66bn | 189.00 | 45.16 | 4.98 | 39.44 | 11.15 | 2.20 | 2.20 | 8.59 | 19.96 | 0.4152 | -- | -- | 5,191,557.00 | 10.64 | 18.70 | 11.38 | 21.27 | 73.81 | 74.18 | 25.62 | 26.20 | -- | -- | 0.00 | 75.30 | 5.09 | 7.99 | 9.20 | 4.22 | 38.51 | -0.6484 |
| Camurus AB | 694.95m | -69.32m | 10.57bn | 149.00 | -- | 12.35 | -- | 15.21 | -1.27 | -1.27 | 12.73 | 15.56 | 0.6551 | 0.8601 | 5.81 | 4,695,635.00 | -6.53 | -27.66 | -8.06 | -33.82 | 86.21 | 86.73 | -9.98 | -84.90 | 2.64 | -66.37 | 0.0273 | -- | 78.74 | 39.49 | 45.93 | -- | 1.59 | -- |
| Swedencare AB (publ) | 1.02bn | 39.41m | 13.74bn | 517.00 | 250.76 | 2.12 | 85.48 | 13.48 | 0.3466 | 0.3466 | 8.34 | 41.01 | 0.1924 | 2.10 | 7.47 | 3,640,225.00 | 0.7438 | 4.78 | 0.7873 | 5.07 | 48.70 | 57.82 | 3.87 | 11.94 | 1.11 | 3.35 | 0.1974 | 32.49 | 221.77 | 70.46 | 63.76 | 41.06 | -- | -- |
| Karo Pharma AB | 2.96bn | -17.25m | 13.88bn | 242.00 | -- | 1.98 | 58.91 | 4.69 | -0.0617 | -0.0617 | 13.13 | 25.68 | 0.2359 | -- | -- | 12,262,750.00 | -0.1353 | 1.79 | -0.1761 | 2.49 | 57.62 | 55.56 | -0.5737 | 7.45 | 1.69 | 1.06 | 0.4964 | 3.50 | 2.72 | 53.52 | -121.27 | -- | -4.89 | -- |
| AddLife AB | 8.84bn | 717.60m | 19.20bn | 2.12k | 27.75 | 4.36 | 14.81 | 2.17 | 5.87 | 5.87 | 72.26 | 37.35 | 1.05 | 5.11 | 7.11 | 4,903,219.00 | 8.53 | 9.03 | 16.54 | 17.10 | 36.61 | 35.74 | 8.14 | 7.57 | 0.3139 | 9.79 | 0.5357 | 34.17 | 51.57 | -- | 38.78 | -- | -- | -- |
| Bavarian Nordic A/S | 2.73bn | -668.08m | 24.53bn | 759.00 | -- | 2.31 | -- | 8.99 | -7.48 | -7.48 | 30.41 | 104.70 | 0.1821 | 2.65 | 7.09 | 2,500,494.00 | -4.46 | -2.42 | -5.17 | -2.93 | 30.05 | 45.79 | -24.49 | -11.37 | 2.24 | -7.69 | 0.3584 | -- | 2.46 | 13.52 | -267.47 | -- | 49.64 | -- |
| Vitrolife AB | 2.05bn | 304.76m | 29.12bn | 1.17k | 84.38 | 1.87 | 59.43 | 14.18 | 2.55 | 2.55 | 16.93 | 114.69 | 0.1864 | 3.03 | 6.30 | 4,809,944.00 | 2.78 | 8.88 | 2.94 | 9.55 | 59.31 | 63.53 | 14.93 | 24.08 | 1.17 | 23.18 | 0.1365 | 23.22 | 34.94 | 14.45 | 18.87 | 12.36 | 35.34 | 9.00 |
| ALK-Abello A/S | 5.82bn | 366.55m | 35.96bn | 2.57k | 106.26 | 7.44 | 48.86 | 6.18 | 1.16 | 1.16 | 18.45 | 16.60 | 0.6892 | 1.34 | 5.89 | 1,596,374.00 | 4.34 | -0.5115 | 5.47 | -0.6163 | 61.85 | 58.11 | 6.30 | -0.8118 | 0.9756 | 20.06 | 0.146 | -- | 12.17 | 5.44 | 776.00 | -4.10 | 3.17 | -- |
Data as of Jun 23 2022. Currency figures normalised to AddLife AB's reporting currency: Swedish Krona SEK
43.83%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| SEB Investment Management ABas of 28 Feb 2022 | 10.99m | 9.33% |
| Swedbank Robur Fonder ABas of 19 Apr 2022 | 8.18m | 6.94% |
| Fidelity Management & Research Co. LLCas of 30 Apr 2022 | 6.70m | 5.69% |
| Capital Research & Management Co. (World Investors)as of 25 Oct 2021 | 5.32m | 4.52% |
| Handelsbanken Fonder ABas of 31 May 2022 | 5.21m | 4.42% |
| ODIN Forvaltning AS (Sweden)as of 31 May 2022 | 3.50m | 2.97% |
| ODIN Forvaltning ASas of 31 May 2022 | 3.33m | 2.83% |
| AMF Fonder ABas of 01 Mar 2022 | 2.96m | 2.51% |
| The Vanguard Group, Inc.as of 02 Jun 2022 | 2.92m | 2.48% |
| Lannebo Fonder ABas of 28 Feb 2022 | 2.54m | 2.16% |
More ▼
Data from 31 Mar 2022 - 31 May 2022Source: FactSet Research Systems Inc.
